ReviewBioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy2026
Targeting MYC-Driven Cancers: From Oncogenic Addiction to Therapeutic Vulnerability.
Lourdes Sainero-Alcolado et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.